
01 October 2026Event
Brussels HLS Day
The Future of Health Regulation 2026 – Pharma, MedTech & Data in Transition
ECCTA is a wide-ranging piece of legislation, addressing a number of issues, but broadly themed around measures to prevent financial crime and to promote transparency in the ownership and use of corporate structures. It contains diverse and unrelated provisions, some of which came into force immediately in December 2023, while others will be brought into force throughout 2024 and into 2025.
Companies and partnerships will need to take steps to address some of what ECCTA brings immediately, while other changes cannot effectively be addressed until they are clarified by secondary legislation or government guidance.
This document (and any information accessed through links in this document) is provided for information purposes only and does not constitute legal advice. Professional legal advice should be obtained before taking or refraining from any action as a result of the contents of this document.
If you have any questions, contact a member of the Economic Crime and Corporate Transparency Act team for assistance:

01 October 2026Event
The Future of Health Regulation 2026 – Pharma, MedTech & Data in Transition

02 July 2026 Event
Join our upcoming event that will feature speakers from J.P. Morgan, Bank of America, and Simmons & Simmons

02 July 2026 Publication
AI M&A faces unique risks as fast tech, evolving regulation and value drivers demand new diligence, valuation, and deal structures for AI-native targets.

02 July 2026 Publication
Key takeaways and hedging opportunities

01 July 2026 Publication
MAS responds to feedback on proposed enhancements to PHS requirements and complex products framework.